DE3677335D1 - 2-substituierte (2-substituierte amino)-n-aralkyl-3-(indol-3-yl)-propanamide. - Google Patents

2-substituierte (2-substituierte amino)-n-aralkyl-3-(indol-3-yl)-propanamide.

Info

Publication number
DE3677335D1
DE3677335D1 DE8686115859T DE3677335T DE3677335D1 DE 3677335 D1 DE3677335 D1 DE 3677335D1 DE 8686115859 T DE8686115859 T DE 8686115859T DE 3677335 T DE3677335 T DE 3677335T DE 3677335 D1 DE3677335 D1 DE 3677335D1
Authority
DE
Germany
Prior art keywords
substituted
propanamides
indol
aralkyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686115859T
Other languages
English (en)
Inventor
David C Horwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE3677335D1 publication Critical patent/DE3677335D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8686115859T 1985-11-14 1986-11-14 2-substituierte (2-substituierte amino)-n-aralkyl-3-(indol-3-yl)-propanamide. Expired - Fee Related DE3677335D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79806885A 1985-11-14 1985-11-14
US06/912,731 US4757151A (en) 1985-11-14 1986-09-30 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]

Publications (1)

Publication Number Publication Date
DE3677335D1 true DE3677335D1 (de) 1991-03-07

Family

ID=27121955

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686115859T Expired - Fee Related DE3677335D1 (de) 1985-11-14 1986-11-14 2-substituierte (2-substituierte amino)-n-aralkyl-3-(indol-3-yl)-propanamide.

Country Status (8)

Country Link
US (1) US4757151A (de)
EP (1) EP0224151B1 (de)
AU (1) AU582921B2 (de)
CA (1) CA1274350A (de)
DE (1) DE3677335D1 (de)
DK (1) DK168006B1 (de)
ES (1) ES2032376T3 (de)
GR (1) GR3001413T3 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326108C (en) * 1988-04-12 1994-01-11 Sun Hyuk Kim Cck antagonists
US5010089A (en) * 1988-08-12 1991-04-23 Biomeasure, Inc. CCK antagonists and their use in treating gastrointestinal disorders
US5580896A (en) * 1989-06-29 1996-12-03 Warner-Lambert Company Treatment of pain and colorectal cancer with dipeptoids of α-substituted Trp-Phe derivatives
US5631281A (en) * 1989-06-29 1997-05-20 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted Trp-Phe- and phenethylamine derivatives
US5278316A (en) * 1989-06-29 1994-01-11 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives
NZ234264A (en) * 1989-06-29 1993-05-26 Warner Lambert Co N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions
CA2088195A1 (en) * 1990-08-31 1992-03-01 David C. Horwell Cholecystokinin antagonists, their preparation and therapeutic use
DE69132805T2 (de) * 1990-08-31 2002-10-24 Warner-Lambert Co., Ann Arbor Pro-medikamente für cck-antagonisten
US5244915A (en) * 1990-08-31 1993-09-14 Warner-Lambert Company Amico acid derivatives cyclized at the c-terminal
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
US5593967A (en) * 1990-08-31 1997-01-14 Warner-Lambert Company Cholecystokinin antagonists, their preparation and therapeutic use
US5340825A (en) * 1990-08-31 1994-08-23 Warner-Lambert Company Pro drugs for CCK antagonists
US5244905A (en) * 1990-08-31 1993-09-14 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl polyhydro-β-carboline-phenylalanine- and phenethylamine derivatives
PL181782B1 (pl) * 1993-08-10 2001-09-28 Black James Foundation Nowe zwiazki i sposób wytwarzania nowych zwiazków PL
US6869957B1 (en) 1993-11-17 2005-03-22 Eli Lilly And Company Non-peptide tachykinin receptor antagonists
US6403577B1 (en) * 1993-11-17 2002-06-11 Eli Lilly And Company Hexamethyleneiminyl tachykinin receptor antagonists
US5554644A (en) * 1994-06-08 1996-09-10 Warner-Lambert Company Tachykinin (NK2) antagonists
CA2224062C (en) * 1995-06-06 2001-09-04 Pfizer Limited Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
GB2338235B (en) 1997-04-15 2001-11-14 Csir Appetite suppressing plant extracts
GB2396815B (en) 1999-10-27 2004-09-08 Phytopharm Plc A composition comprising a pregnenone derivative and an NSAID
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
AU1312502A (en) * 2000-10-11 2002-04-22 Pe Corp Ny Fluorescent nucleobase conjugates having anionic linkers
KR101492351B1 (ko) * 2010-09-22 2015-02-10 미쓰이가가쿠 아그로 가부시키가이샤 함불소 카바메이트기를 가지는 아미노산 아미드 유도체의 제조방법, 그 제조 중간체, 및 에틸렌디아민 유도체의 제조방법
CN118812515A (zh) * 2023-04-21 2024-10-22 中国科学技术大学 抑制gsdme蛋白膜穿孔功能的化合物或其药学上可接受的盐及其制备方法与应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899592A (en) * 1968-04-08 1975-08-12 Lilly Co Eli Sweetening agent
US3676458A (en) * 1970-06-11 1972-07-11 Lilly Co Eli (indolymethyl) malonate compound
CA1044142A (en) * 1975-07-04 1978-12-12 John N. Mcarthur Anti-inflammatory dipeptide
US3965260A (en) * 1975-07-07 1976-06-22 John N. McArthur Anti-inflammatory dipeptide
US4256641A (en) * 1976-06-22 1981-03-17 Hoffmann-La Roche Inc. Novel syntheses of tryptophans
US4073795A (en) * 1976-06-22 1978-02-14 Hoffmann-La Roche Inc. Synthesis of tryptophans
US4137404A (en) * 1977-12-20 1979-01-30 Hoffmann-La Roche Inc. Synthesis of tryptophans
US4198501A (en) * 1977-12-20 1980-04-15 Hoffmann-La Roche Inc. Synthesis of tryptophans
DE2901667A1 (de) * 1979-01-17 1980-07-31 Troponwerke Gmbh & Co Kg Pharmazeutische verwendung von dipeptiden
DE2904512A1 (de) * 1979-02-07 1980-08-28 Troponwerke Gmbh & Co Kg Dehydropeptide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines
US4623729A (en) * 1982-07-22 1986-11-18 E. R. Squibb & Sons, Inc. Acylalkylaminocarbonyl substituted amino and imino acid compounds
US4482567A (en) * 1982-10-07 1984-11-13 Research Foundation For Mental Hygiene, Inc. N-hexanoyl to n-heptadecanoyl 5-hydroxy tryptophan-5-hydroxytryptophanamides and use as analgesics
JPS6028988A (ja) * 1983-06-29 1985-02-14 Ajinomoto Co Inc ペプチドの製造方法
EP0166355A2 (de) * 1984-06-26 1986-01-02 Merck & Co. Inc. Substituierte Aminophenyl- und Acylaminophenyl-Verbindungen und deren pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
EP0224151A3 (en) 1989-02-22
US4757151A (en) 1988-07-12
DK168006B1 (da) 1994-01-17
DK540986A (da) 1987-05-15
GR3001413T3 (en) 1992-09-25
DK540986D0 (da) 1986-11-12
AU6507386A (en) 1987-05-21
ES2032376T3 (es) 1993-02-16
AU582921B2 (en) 1989-04-13
EP0224151B1 (de) 1991-01-30
EP0224151A2 (de) 1987-06-03
CA1274350A (en) 1990-09-18

Similar Documents

Publication Publication Date Title
DE3677335D1 (de) 2-substituierte (2-substituierte amino)-n-aralkyl-3-(indol-3-yl)-propanamide.
FI860281A7 (fi) Peptidderivat.
FI870810L (fi) Aminosyraderivater.
FI862655A7 (fi) (4-piperidinyl- och -hetero)puriner.
FI870621L (fi) Bradykininantagonistspeptider.
DE3685167D1 (de) Calcitoningen-verwandte peptidderivate.
FI855177A0 (fi) Valspress med en laongslits-pressvals.
ATE53997T1 (de) N-substituierte diphenylpiperidine.
FI853464A0 (fi) Reaktor med cirkulerande baedd.
FI861404L (fi) Barnstol foer aokdon.
DE3582728D1 (de) Tertiaere aminoverbindungen.
FI863242A7 (fi) Benzimidazolderivat.
FI862954A0 (fi) Korrigeringsanordning foer braensle-luftfoerhaollande ( ) i en braennmotors turbofoergasare.
DE3677787D1 (de) Aminderivate.
FI872997A7 (fi) Amidijohdannaisia.
FI860978L (fi) Spjaelgaller foer saengar.
FI853115L (fi) Laoshus foersett med dubbelregel.
FI860029L (fi) Somatostatinderivat.
ATE60581T1 (de) 2-substituierte (2-substituierte amino>-n-aralkyl-3-(indol-3-yl>-propanamide.
FI854561A7 (fi) Med minst en kopplingsbar friktionskoppling foersedd drivanordning foer fartyg.
DE3676000D1 (de) Baublock.
FI864146L (fi) Mitogena peptider.
FI854982A0 (fi) Rullstaell med broms.
FI851537A0 (fi) Amfibieplan med katamaranskrov (avtrappat).
ATE45067T1 (de) Eiweisshydrolysat.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee